AT292929B - Verfahren zur Herstellung von 17α-Monoestern von 11β,17α,21-Trihydroxysteroiden - Google Patents

Verfahren zur Herstellung von 17α-Monoestern von 11β,17α,21-Trihydroxysteroiden

Info

Publication number
AT292929B
AT292929B AT38169A AT38169A AT292929B AT 292929 B AT292929 B AT 292929B AT 38169 A AT38169 A AT 38169A AT 38169 A AT38169 A AT 38169A AT 292929 B AT292929 B AT 292929B
Authority
AT
Austria
Prior art keywords
trihydroxysteroids
monoesters
preparation
Prior art date
Application number
AT38169A
Other languages
English (en)
Original Assignee
Koninklijke Gist Spiritus
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Koninklijke Gist Spiritus filed Critical Koninklijke Gist Spiritus
Application granted granted Critical
Publication of AT292929B publication Critical patent/AT292929B/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F21LIGHTING
    • F21VFUNCTIONAL FEATURES OR DETAILS OF LIGHTING DEVICES OR SYSTEMS THEREOF; STRUCTURAL COMBINATIONS OF LIGHTING DEVICES WITH OTHER ARTICLES, NOT OTHERWISE PROVIDED FOR
    • F21V17/00Fastening of component parts of lighting devices, e.g. shades, globes, refractors, reflectors, filters, screens, grids or protective cages
    • F21V17/10Fastening of component parts of lighting devices, e.g. shades, globes, refractors, reflectors, filters, screens, grids or protective cages characterised by specific fastening means or way of fastening
    • F21V17/20Fastening of component parts of lighting devices, e.g. shades, globes, refractors, reflectors, filters, screens, grids or protective cages characterised by specific fastening means or way of fastening by toggle-action levers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Engineering & Computer Science (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT38169A 1968-01-23 1969-01-15 Verfahren zur Herstellung von 17α-Monoestern von 11β,17α,21-Trihydroxysteroiden AT292929B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB358768 1968-01-23

Publications (1)

Publication Number Publication Date
AT292929B true AT292929B (de) 1971-09-10

Family

ID=9761163

Family Applications (1)

Application Number Title Priority Date Filing Date
AT38169A AT292929B (de) 1968-01-23 1969-01-15 Verfahren zur Herstellung von 17α-Monoestern von 11β,17α,21-Trihydroxysteroiden

Country Status (12)

Country Link
US (1) US3557162A (de)
AT (1) AT292929B (de)
BE (1) BE726981A (de)
CH (1) CH511822A (de)
DE (1) DE1903118A1 (de)
DK (1) DK120234B (de)
ES (1) ES362475A1 (de)
FR (2) FR8225M (de)
GB (1) GB1227992A (de)
IT (1) IT1036015B (de)
NL (1) NL162083C (de)
SE (1) SE339828B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1033042B (it) * 1970-03-14 1979-07-10 Luso Farmaco Inst Desametazone 17 valerato e processi per la sua preparazione
DE2512915A1 (de) * 1974-03-27 1975-10-09 Plurichemie Anstalt 16-methyl-9 alpha-halogen-steroide ester, aether und verfahren zu ihrer herstellung
US4036831A (en) * 1975-10-28 1977-07-19 Steroid Development Company Establishment Trimethyl siloxane steroid intermediates
DE3442527A1 (de) * 1983-11-23 1985-05-30 Bösha GmbH & Co KG, 4780 Lippstadt Langfeldleuchte fuer den einsatz in schlagwetter- und explosionsgeschuetzten bereichen
GB0019172D0 (en) * 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
US6777399B2 (en) * 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
EP2067784A3 (de) 2000-08-05 2012-08-22 Glaxo Group Limited 17.beta.-Carbothioat-17.alpha.-Arylcarbonyloxyloxy-Androstan-Derivate als entzündungshemmende Mittel
US6759398B2 (en) * 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
US6858596B2 (en) * 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
MXPA03009940A (es) * 2001-04-30 2004-01-29 Glaxo Group Ltd DERIVADOS ANTI-INFLAMATORIOS DE 17. BETA-CARBOTIOATO ESTER DE ANDROSTANO CON UN GRUPO DE ESTER CICLICO EN LA POSICIoN 17.ALFA.
ATE399174T1 (de) * 2001-06-12 2008-07-15 Glaxo Group Ltd Neue anti inflammatorische 17.alpha.- heterozyklische ester von 17.beta.-carbothioat androstan derivativen
US20050175545A1 (en) * 2002-02-04 2005-08-11 Keith Biggadike Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist
GB0202635D0 (en) * 2002-02-05 2002-03-20 Glaxo Wellcome Mfg Pte Ltd Formulation containing novel anti-inflammatory androstane derivative
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
GB0507165D0 (en) * 2005-04-08 2005-05-18 Glaxo Group Ltd Novel crystalline pharmaceutical product
GB0615108D0 (en) * 2006-07-28 2006-09-06 Glaxo Group Ltd Novel formulations
NO331891B1 (no) * 2007-03-20 2012-04-30 Clavis Pharma Asa Kjemiske forbindelser, et farmasoytisk preparat inneholdende slike forbindelser, samt anvendelse derav for behandling av kreft, inflammasjon og KOLS
UA116622C2 (uk) 2011-11-11 2018-04-25 Аллерган, Інк. Похідні 4-прегенен-11ss-17-21-тріол-3,20-діону для лікування хвороб очей

Also Published As

Publication number Publication date
IT1036015B (it) 1979-10-30
FR2000571A1 (de) 1969-09-12
DK120234B (da) 1971-05-03
GB1227992A (de) 1971-04-15
FR8225M (de) 1970-09-28
NL162083B (nl) 1979-11-15
NL162083C (nl) 1980-04-15
US3557162A (en) 1971-01-19
CH511822A (de) 1971-08-31
BE726981A (de) 1969-07-16
NL6901024A (de) 1969-07-25
DE1903118A1 (de) 1969-08-07
SE339828B (de) 1971-10-25
ES362475A1 (es) 1970-12-01

Similar Documents

Publication Publication Date Title
AT292929B (de) Verfahren zur Herstellung von 17α-Monoestern von 11β,17α,21-Trihydroxysteroiden
AT281311B (de) Verfahren zur Herstellung von 11β,17α-Dihydroxysteroiden
CH508616A (de) Verfahren zur Herstellung von 2-Alkyl-3-hydroxy-4,5-dihydrofuran-4-onen
AT303981B (de) Verfahren zur Herstellung von neuen Steroiden
CH468985A (de) Verfahren zur Herstellung von 19-nor- 4,9(10)-Steroiden
CH525876A (de) Verfahren zur Herstellung von 3-Keto-6,7-methylen-20-spirox-4-enen
CH481081A (de) Verfahren zur Herstellung von 1,2B-Methylensteroiden
CH540896A (de) Verfahren zur Herstellung von 15,16B-Methylensteroiden
CH527807A (de) Verfahren zur Herstellung von Steroidderivaten
CH536827A (de) Verfahren zur Herstellung von 6-Hydroxy-3-keto- 1,4-Steroiden der Pregnan- und Androstanreihe
CH478111A (de) Verfahren zur Herstellung von 17a-Acyloxy-21-hydroxy-steroiden der Pregnanreihe
CH521957A (de) Verfahren zur Herstellung von 1,3,5(10)-Steroiden der 3-Hydroxyreihe
AT293638B (de) Verfahren zur Herstellung von 3β,14β-Dihydroxy-carda-4,20(22)-dien-oliden
CH461480A (de) Verfahren zur Herstellung von 6a, 9a-Difluor-16-methylen-1,4-pregnadien-3,20-dion-11B,17a-diol
CH472397A (de) Verfahren zur Herstellung von 6-Halogen-1a,2a-methylen-16a-methyl- 4,6-pregnadien-17-ol-3,20-dionen
CH481085A (de) Verfahren zur Herstellung von 11B-Hydroxy-17 -alkanoyloxysteroiden der Pregnanreihe
CH459197A (de) Verfahren zur Herstellung von 7a, 16a-Dialkyl-steroiden der Pregnanreihe
AT252475B (de) Verfahren zur Herstellung von Pregnan-Derivaten
CH483409A (de) Verfahren zur Herstellung von 19-Hydroxy- 4-3-ketosteroiden
AT301770B (de) Verfahren zur Herstellung von 17α-Propadienylsteroiden
AT315387B (de) Verfahren zur Herstellung von neuen 14,15β-Epoxycardenoliden
CH453353A (de) Verfahren zur Herstellung von 3B-Oxy- 1(10),5-19-nor-steroiden der Androstanreihe
AT290744B (de) Verfahren zur Herstellung von neuen Steroiden
CH530384A (de) Verfahren zur Herstellung von 3B,11B-Dihydroxy-5a,6a-epoxysteroiden
CH481082A (de) Verfahren zur Herstellung von 6,1'-Spirocyclopropylverbindungen der Androstanreihe

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee